Neuroendocrine neoplasms of the lung: Concepts and terminology.
Neuroendocrine neoplasms of the lung continue to undergo scrutiny, with respect to the diagnostic terminology recommended for them and details of their clinicopathologic profiles. This overview considers the nosological evolution of such lesions and presents current views on classification schemes that pertain to them.
Division of Surgical Pathology, University of Virginia Medical Center, 1215 Lee St, Charlottesville, Virginia 22908-0214; Division of Surgical Pathology, Cedars-Sinai Medical Center, Los Angeles, California. Electronic address: mrw9c@virginia.edu.
Mark R
MR
Wick
Division of Surgical Pathology, University of Virginia Medical Center, 1215 Lee St, Charlottesville, Virginia 22908-0214; Division of Surgical Pathology, Cedars-Sinai Medical Center, Los Angeles, California.
Alberto M
AM
Marchevsky
D017209:Apoptosis; D014408:Biomarkers, Tumor / Q000032:analysis; D001706:Biopsy; D049109:Cell Proliferation; D006801:Humans; D007150:Immunohistochemistry; D008175:Lung Neoplasms / Q000737:chemistry / Q000145:classification / Q000473:pathology*; D009336:Necrosis; D055099:Neuroendocrine Cells / Q000737:chemistry / Q000145:classification / Q000473:pathology*; D018358:Neuroendocrine Tumors / Q000737:chemistry / Q000145:classification / Q000473:pathology*; D011237:Predictive Value of Tests; D011379:Prognosis; D009626:Terminology as Topic; D014057:Tomography, X-Ray Computed
D014408:Biomarkers, Tumor
Carcinoid tumors; Large-cell neuroendocrine carcinoma; Neuroendocrine neoplasms; Small-cell carcinoma; Tumor classification